The Patent Finder

Adenosine Therapeutics, LLC

Also on record
Records under this name other than the patents Adenosine Therapeutics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Adenosine Therapeutics, LLC

PatentTitleStatus Expires Confidence
US 7,598,379Methods for the Synthesis of Unsymmetrical Cycloalkyl Substituted Xanthines
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,605,1432-Propynyl Adenosine Analogs with Modifed 5'-Ribose Groups Having A2A Agonist Activity
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,342,006Substituted 8-Heteroaryl Xanthines
Formerly held
Term ended
Term ended Nov 7, 2025 · High confidence
Term endedTerm ended Nov 7, 2025High confidence
US 8,420,813Methods for the Synthesis of Unsymmetrical Cycloalkyl Substituted Xanthines
Formerly held
Lapsed on the fee record
Ended Apr 16, 2025 · High confidence
Lapsed on the fee recordEnded Apr 16, 2025High confidence
US 7,732,455Substituted 8-Heteroaryl Xanthines
Formerly held
Term ended
Term ended Aug 20, 2024 · High confidence
Term endedTerm ended Aug 20, 2024High confidence
US 8,188,063Use of Adenosine A2A Modulators to Treat Spinal Cord Injury
Formerly held
Lapsed on the fee record
Ended May 29, 2024 · High confidence
Lapsed on the fee recordEnded May 29, 2024High confidence
US 8,178,509Method to Treat Sickle Cell Disease
Formerly held
Lapsed on the fee record
Ended May 15, 2024 · High confidence
Lapsed on the fee recordEnded May 15, 2024High confidence
US 7,884,100Substituted 8-[6-Amino-3-Pyridyl]XANTHINES
Formerly held
Lapsed on the fee record
Ended Feb 8, 2023 · High confidence
Lapsed on the fee recordEnded Feb 8, 2023High confidence
US 8,551,972Agonists of A2A Adenosine Receptors for Treating Recurrent Tumor Growth
Lapsed on the fee record
Ended Oct 8, 2021 · High confidence
Lapsed on the fee recordEnded Oct 8, 2021High confidence
US 9,555,129Adenosine derivative formulations for medical imaging
Lapsed on the fee record
Ended Jan 31, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jan 31, 2021From the USPTO record
10 of 27 patents shown.
Pro members see all 27.
Pro members: see all 27 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited